First, SS promotes CLDN1, which is significantly negatively associated with the risk of thyroid carcinoma (p(HR) = 0.031), suggesting a potential beneficial role in TC survival through the SS-CLDN1-TC pathway. Here, CLDN1 is linked to thyroid gland carcinoma.